M
Masashi Mizokami
Researcher at Nagoya City University
Publications - 684
Citations - 37168
Masashi Mizokami is an academic researcher from Nagoya City University. The author has contributed to research in topics: Hepatitis B virus & Hepatitis C virus. The author has an hindex of 85, co-authored 650 publications receiving 34868 citations. Previous affiliations of Masashi Mizokami include National Institute of Advanced Industrial Science and Technology & University of Florida.
Papers
More filters
Journal ArticleDOI
Natural history of bleeding risk in colonic diverticulosis patients: a long‐term colonoscopy‐based cohort study
Ryota Niikura,Naoyoshi Nagata,T. Shimbo,Tomonori Aoki,Atsuo Yamada,Yoshihiro Hirata,K Sekine,H Okubo,K. Watanabe,T. Sakurai,C. Yokoi,Masashi Mizokami,M. Yanase,J. Akiyama,Kazuhiko Koike,Naomi Uemura +15 more
TL;DR: The natural history of bleeding risk from colonic diverticulosis remains unclear.
Journal ArticleDOI
Multiple intra-familial transmission patterns of hepatitis B virus genotype D in north-eastern Egypt.
Mostafa Ragheb,Abeer Elkady,Yasuhito Tanaka,Shuko Murakami,Fadia M. Attia,Adel A Hassan,Mohamed F. Hassan,Mahmoud M. Shedid,Hassan B. Abdel Reheem,Anis Khan,Masashi Mizokami +10 more
TL;DR: Universal HBV vaccination should be modified by including the first dose at birth with (HBIG) administration to the newborn of mothers infected with HBV.
Journal ArticleDOI
Relationship between polymorphisms of the inosine triphosphatase gene and anaemia or outcome after treatment with pegylated interferon and ribavirin.
Masayuki Kurosaki,Yasuhito Tanaka,Keisuke Tanaka,Yuichiro Suzuki,Y. Hoshioka,Nobuharu Tamaki,T. Kato,Yutaka Yasui,Takanori Hosokawa,Ken Ueda,Kaoru Tsuchiya,Teiji Kuzuya,Hiroyuki Nakanishi,Jun Itakura,Yuka Takahashi,Yasuhiro Asahina,Kentaro Matsuura,Fuminaka Sugauchi,Nobuyuki Enomoto,Nao Nishida,Katsushi Tokunaga,Masashi Mizokami,Namiki Izumi +22 more
TL;DR: Variants of the ITPA gene, which could protect against haemolytic anaemia and RBV dose reduction, were associated with a high rate of SVR by standard PEG-IFN andRBV therapy in a subset of Japanese patients with the favourable TT genotype at rs8099917 of IL28B.
Journal ArticleDOI
Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis
Nao Nishida,Jun Ohashi,Seik-Soon Khor,Masaya Sugiyama,Takayo Tsuchiura,Hiromi Sawai,Keisuke Hino,Masao Honda,Shuichi Kaneko,Hiroshi Yatsuhashi,Osamu Yokosuka,Kazuhiko Koike,Masayuki Kurosaki,Namiki Izumi,Masaaki Korenaga,Jong Hon Kang,Eiji Tanaka,Akinobu Taketomi,Yuichiro Eguchi,Naoya Sakamoto,Kazuhide Yamamoto,Akihiro Tamori,Isao Sakaida,Shuhei Hige,Yoshito Itoh,Satoshi Mochida,Eiji Mita,Yasuhiro Takikawa,Tatsuya Ide,Yoichi Hiasa,Hiroto Kojima,Ken Yamamoto,Minoru Nakamura,Hiroh Saji,Takehiko Sasazuki,Tatsuya Kanto,Katsushi Tokunaga,Masashi Mizokami +37 more
TL;DR: The present study showed an example that SNP-based GWAS does not necessarily detect the primary susceptibility locus in the HLA region.
Journal ArticleDOI
Case-control study for the identification of virological factors associated with fulminant hepatitis B.
Atsunori Kusakabe,Yasuhito Tanaka,Satoshi Mochida,Nobuaki Nakayama,Kazuaki Inoue,Michio Sata,Norio Isoda,Jong-Hon Kang,Yasukiyo Sumino,Hiroshi Yatsuhashi,Yasuhiro Takikawa,Shuichi Kaneko,Gotaro Yamada,Yoshiyasu Karino,Eiji Tanaka,Junji Kato,Isao Sakaida,Namiki Izumi,Fuminaka Sugauchi,Shunsuke Nojiri,Takashi Joh,Yuzo Miyakawa,Masashi Mizokami +22 more
TL;DR: A large number of cases–control studies have been conducted for figuring out virological parameters that can distinguish fulminant hepatitis B from non-FHB, but there have been no case-control studies for figuring them out.